What this covers

The conversation is led by André Perold, an investor and teacher, with Rick and Paul asking questions. It starts with arithmetic. A 2% annual edge over 30 years takes a 22x outcome to roughly 40x, while spending 1% a year from U.S. equities from 1990 to 2022 cuts 21.9x to about 16x, and 2% cuts it to about 12x. That is the case for treating spending as negative compounding. Perold then widens the frame. Drawing on Elroy Dimson's century of data, he notes that Austria went 97 years without a positive real return. Japanese equities returned essentially nothing over about 30 years, and he asks whether U.S. outperformance, helped by escaping wars on its own soil, will last.

The middle of the discussion is about where edges come from and how they disappear. Perold describes the endowment model at Harvard, Yale, Princeton and Notre Dame, and how excess returns faded as private equity grew to about $10 trillion. He calls finance theory an idealized benchmark whose failures create the opportunity. His own answer at HighVista Strategies is to work small: family-owned firms sold through relationships, funds under $500 million, and the roughly 700 small, illiquid public biotechs. His claims that biotech is a talent game played outside big pharma, and that higher rates lower buyout entry prices, are the more contested ones.

Later turns are about people. Perold says teaching improves the teacher's own learning, that student hiring patterns anticipated the 1987 and 2000 downturns, and that not knowing how to program will become a disadvantage as AI spreads. Paul adds that beating the S&P by 2–3% a year would put an investor in the top decile of active managers.

Sharpest takeaway

André Perold argues that compounding is won mainly by avoiding costly spending and losses, by grinding on small, under-served markets that large capital can't efficiently work, and by treating human capital as the most important asset to compound.

  • Spending and fees forgo compounding, so a small annual return edge or drag changes terminal wealth dramatically over 30 years
  • Competition erodes excess returns, so edges must come from frictions that large institutional money cannot economically pursue
  • Human capital is the only asset that doesn't fail with a business, so investing in skills and networks compounds across failures

The argument · threads1 threads · 71 claims
0.85

Sustained 2% to 3% annual outperformance of the S&P would rank an investor in the top active-management decile.

1 pointcentrality 5/5
  • At the top of institutional investing, beating the S&P by 2% to 3% per year over long periods would place an investor in the top decile of all active management.

    “beating the S&P by 2% to 3% per year over long periods would put you right in the top decile of all active management.”